- MarketWatch•3 hours ago
All the ways you can mess up your 401(k) — even if you max out your contributions
Workplace retirement plans get a lot of bad press, primarily if they are loaded with high fees. Put simply, 401(k)s work. The bad news is that otherwise-diligent savers can still leave money on the table with a 401(k), often without realizing it.
- TheStreet.com•yesterday
9 Stocks Goldman Sachs Thinks Will Blow Wall Street's Performance Away in 2019
2018 is just about over, in the minds of some investors. "We expect investors will soon look past 2018 and focus on 2019 growth," says Goldman Sachs strategist David Kostin. "For many years, beginning in July investors would start to value stocks
- TheStreet.com•1 hour ago
3 Simple Tips on Investing From TheStreet's Jim Cramer
Here are three tips for investors to keep in mind from TheStreet's founder Jim Cramer. Keep emotions out of investing, let the trading action and the company's fundamentals dictate your course of action. Says Cramer, "Always remember that once you have done the requisite research your determination of when to buy a stock needs to be strict, it needs to be unemotional.
- Morningstar•2 days ago
Investing Insights: Retirement Buckets and Vanguard Changes
Emerging-markets bond fund picks, dividend-growth funds, and the president's drug plan on this week's episode.
- MarketWatch•6 hours ago
Chip-maker stocks notch losing week after Applied Materials outlook slams sector
Applied Materials Inc. led semiconductor-related stocks to losses Friday and to a weekly decline after the chip-maker materials supplier’s outlook indicated a possible slowing in the recently hot sector. Applied Materials (AMAT) shares fell 8.3% to close at $49.51, after hitting an intraday low of $48.53, as analysts were split on target price moves after the company’s sales outlook was lighter than Wall Street expected. For the week, shares of Applied Materials are down 9.7%, the SOX index swung to a weekly loss of 0.4%, and the S&P 500 (^GSPC) finished down 0.5%.
- TheStreet.com•yesterday
Amazon Could Devastate Walgreens and Rite Aid by Getting Into Pharmacy Business
"Alexa, order me my Lipitor" are five words that could prove financially devastating to pharmacies such as Walgreens Boots Alliance , CVS Health and Rite Aid . With Wall Street waiting on pins and needles to see how Amazon will enter the healthcare
- Fortune•yesterday
Starbucks Announces New Policy: Treat Even Nonpaying Guests Like Customers
Starbucks today announced that it is now official policy to allow all guests in its stores to use its facilities, including restrooms, whether they buy anything or not. The coffee chain had previously lacked a clear policy on the question. That ambiguity
- Bloomberg•yesterday
Tesla Shareholders Urged to Separate Chairman's Role From Musk
The largest proxy advisory firm is recommending that investors reject two of Tesla Inc.’s board members, while also supporting a proposal to split the role of chairman and chief executive officer -- jobs now held by Elon Musk, the public face of the electric-car maker. By opposing directors Antonio Gracias and James Murdoch, and seeking to install an independent chairman, Institutional Shareholder Services is ratcheting up the pressure on Tesla to reform its nine-member board in the wake of production delays on its mass-market Model 3. "Shareholders would benefit from the strongest form of independent board oversight in the form of an independent chair," ISS wrote in a report to clients.
- TheStreet.com•yesterday
Apple Buys Tesla? Amazon Buys Sears? 3 Dream Mergers That Just Make Sense
One can dream, right? There has been a whopping $1.85 trillion in global M&A so far in 2018, according to Dealogic, from 12,659 total deals. But there are three deals that would make some serious headlines. Amazon Buys Sears This seems unorthodox
- TechCrunch•yesterday
Apple started paying $15 billion European tax fine
It took a couple of years, but Apple has started to pay back illegal tax benefits to the Irish government. Apple has to pay $15 billion in total (€13 billion). In August 2016, the European Commission said that Apple benefited from illegal tax benefits in Ireland from 2003 to 2014.
- TheStreet.com•10 hours ago
Macy's Vs. J.C. Penney: Which Department Store Is Just Trying to Survive?
is the older sister (159 years) to J.C. Penney Co. (116), yet there was more than age at play in this week's earnings reports of each. Macy's reported a strong first quarter, which shone all the more brightly because of its past weaknesses.
- Oilprice.com•yesterday
The Double-Edged Sword Of High Oil Prices
Rising oil prices were seen last year as a positive result of growing global growth and recovery, but a combination of factors is turning this benign view into a more sinister scenario. As a result, oil prices have gradually risen during the period. It’s a trend most observers have been sanguine about, believing the U.S.’s tight oil producers, encouraged by rising prices, will increase output to ensure ample supply and keep a lid on oil prices getting ahead of themselves.
- The Wall Street Journal•2 days ago
Theranos Inc.’s Partners in Blood
Theranos Inc.’s 15-year quest to revolutionize the blood-testing industry met with the latest in a series of crippling blows in March when the Securities and Exchange Commission charged the Silicon Valley diagnostics firm with conducting an “elaborate, years-long fraud.” The SEC accused the firm of deceiving investors into believing that its portable device could perform a broad range of laboratory tests on drops of blood pricked from a finger, when in fact it was doing most of its tests on commercial analyzers made by others. Much of the attention has focused on Theranos founder Elizabeth Holmes. Mr. Balwani, who met Ms. Holmes when she was a teenager, jointly ran the company with her for seven years as president and chief operating officer and enforced a corporate culture of secrecy and fear until his departure in the spring of 2016, the former employees say.
Reuters•2 days agoISS sides against two Tesla directors, backs split of Musk's roles
ISS also backed two shareholder proposals to be voted on at the company's annual meeting set for June 5, including one that would require it to separate the current chairman and CEO roles of founder Elon Musk. "The complexity of large-scale manufacturing and the challenges of successfully commercializing new technologies and new manufacturing and marketing techniques suggest that shareholders would be better served by having Musk focus on running the company, and allowing an independent director to run the board," according to a copy of ISS' recommendations seen by Reuters.
- CNBC Videos•2 days ago
The Look Ahead: May 18, 2018
CNBC brings you fast, accurate, and actionable business news and market updates.
